- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.50 Å
- Oligo State
- hetero-3-3-mer
- Ligands
- 3 x FES: FE2/S2 (INORGANIC) CLUSTER(Non-covalent)
- 3 x FE: FE (III) ION(Non-covalent)
FE.2: 3 residues within 4Å:- Chain A: H.206, H.211, D.360
5 PLIP interactions:3 interactions with chain A, 2 Ligand-Water interactions- Metal complexes: A:H.206, A:H.211, A:D.360, H2O.9, H2O.17
FE.22: 3 residues within 4Å:- Chain C: H.206, H.211, D.360
5 PLIP interactions:3 interactions with chain C, 2 Ligand-Water interactions- Metal complexes: C:H.206, C:H.211, C:D.360, H2O.37, H2O.45
FE.42: 3 residues within 4Å:- Chain E: H.206, H.211, D.360
5 PLIP interactions:3 interactions with chain E, 2 Ligand-Water interactions- Metal complexes: E:H.206, E:H.211, E:D.360, H2O.65, H2O.73
- 3 x 3NT: 3-NITROTOLUENE(Non-covalent)
3NT.3: 12 residues within 4Å:- Chain A: N.199, F.200, D.203, G.204, H.206, V.207, N.258, F.293, N.295, L.305, I.350, W.356
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:V.207, A:F.293, A:F.293, A:N.295
- pi-Stacking: A:F.200, A:H.206
3NT.23: 12 residues within 4Å:- Chain C: N.199, F.200, D.203, G.204, H.206, V.207, N.258, F.293, N.295, L.305, I.350, W.356
6 PLIP interactions:6 interactions with chain C- Hydrophobic interactions: C:V.207, C:F.293, C:F.293, C:N.295
- pi-Stacking: C:F.200, C:H.206
3NT.43: 12 residues within 4Å:- Chain E: N.199, F.200, D.203, G.204, H.206, V.207, N.258, F.293, N.295, L.305, I.350, W.356
6 PLIP interactions:6 interactions with chain E- Hydrophobic interactions: E:V.207, E:F.293, E:F.293, E:N.295
- pi-Stacking: E:F.200, E:H.206
- 18 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.4: 7 residues within 4Å:- Chain A: P.47, S.48, D.51
- Chain B: R.78, Y.79, Q.80, L.81
Ligand excluded by PLIPEDO.5: 5 residues within 4Å:- Chain A: K.30, R.35, D.151, S.425, N.426
Ligand excluded by PLIPEDO.6: 10 residues within 4Å:- Chain A: V.53, K.54, E.90, P.184, K.186, W.325
- Chain B: E.70, R.183
- Ligands: EOH.7, EOH.8
Ligand excluded by PLIPEDO.14: 6 residues within 4Å:- Chain B: Y.50, Y.88, Q.102, L.191, V.192, F.193
Ligand excluded by PLIPEDO.15: 5 residues within 4Å:- Chain B: M.2, N.4, E.7
- Chain F: H.56
- Ligands: NI.13
Ligand excluded by PLIPEDO.16: 8 residues within 4Å:- Chain B: T.35, T.39, V.120, V.123
- Chain D: T.121, N.122
- Ligands: EDO.36, EDO.56
Ligand excluded by PLIPEDO.24: 7 residues within 4Å:- Chain C: P.47, S.48, D.51
- Chain D: R.78, Y.79, Q.80, L.81
Ligand excluded by PLIPEDO.25: 5 residues within 4Å:- Chain C: K.30, R.35, D.151, S.425, N.426
Ligand excluded by PLIPEDO.26: 10 residues within 4Å:- Chain C: V.53, K.54, E.90, P.184, K.186, W.325
- Chain D: E.70, R.183
- Ligands: EOH.27, EOH.28
Ligand excluded by PLIPEDO.34: 6 residues within 4Å:- Chain D: Y.50, Y.88, Q.102, L.191, V.192, F.193
Ligand excluded by PLIPEDO.35: 5 residues within 4Å:- Chain B: H.56
- Chain D: M.2, N.4, E.7
- Ligands: NI.33
Ligand excluded by PLIPEDO.36: 8 residues within 4Å:- Chain D: T.35, T.39, V.120, V.123
- Chain F: T.121, N.122
- Ligands: EDO.16, EDO.56
Ligand excluded by PLIPEDO.44: 7 residues within 4Å:- Chain E: P.47, S.48, D.51
- Chain F: R.78, Y.79, Q.80, L.81
Ligand excluded by PLIPEDO.45: 5 residues within 4Å:- Chain E: K.30, R.35, D.151, S.425, N.426
Ligand excluded by PLIPEDO.46: 10 residues within 4Å:- Chain E: V.53, K.54, E.90, P.184, K.186, W.325
- Chain F: E.70, R.183
- Ligands: EOH.47, EOH.48
Ligand excluded by PLIPEDO.54: 6 residues within 4Å:- Chain F: Y.50, Y.88, Q.102, L.191, V.192, F.193
Ligand excluded by PLIPEDO.55: 5 residues within 4Å:- Chain D: H.56
- Chain F: M.2, N.4, E.7
- Ligands: NI.53
Ligand excluded by PLIPEDO.56: 8 residues within 4Å:- Chain B: T.121, N.122
- Chain F: T.35, T.39, V.120, V.123
- Ligands: EDO.16, EDO.36
Ligand excluded by PLIP- 27 x EOH: ETHANOL(Non-functional Binders)
EOH.7: 8 residues within 4Å:- Chain A: L.45, V.53, G.182, P.183, P.184, Y.327
- Chain B: E.70
- Ligands: EDO.6
Ligand excluded by PLIPEOH.8: 9 residues within 4Å:- Chain A: K.54, A.55, K.56, E.61, E.90, K.186, W.325
- Chain F: E.149
- Ligands: EDO.6
Ligand excluded by PLIPEOH.9: 3 residues within 4Å:- Chain A: S.141, F.142, H.143
Ligand excluded by PLIPEOH.10: 4 residues within 4Å:- Chain A: V.87, H.88, A.89
- Chain F: N.111
Ligand excluded by PLIPEOH.11: 5 residues within 4Å:- Chain A: E.153, A.154, P.155, W.427, E.431
Ligand excluded by PLIPEOH.17: 7 residues within 4Å:- Chain B: P.112, K.113, I.114, A.146, R.147, R.148
- Chain D: L.71
Ligand excluded by PLIPEOH.18: 6 residues within 4Å:- Chain B: D.46, R.115, F.116, T.117
- Chain D: R.138, T.158
Ligand excluded by PLIPEOH.19: 3 residues within 4Å:- Chain B: E.55, H.56, K.172
Ligand excluded by PLIPEOH.20: 2 residues within 4Å:- Chain B: N.4, Q.6
Ligand excluded by PLIPEOH.27: 8 residues within 4Å:- Chain C: L.45, V.53, G.182, P.183, P.184, Y.327
- Chain D: E.70
- Ligands: EDO.26
Ligand excluded by PLIPEOH.28: 9 residues within 4Å:- Chain B: E.149
- Chain C: K.54, A.55, K.56, E.61, E.90, K.186, W.325
- Ligands: EDO.26
Ligand excluded by PLIPEOH.29: 3 residues within 4Å:- Chain C: S.141, F.142, H.143
Ligand excluded by PLIPEOH.30: 4 residues within 4Å:- Chain B: N.111
- Chain C: V.87, H.88, A.89
Ligand excluded by PLIPEOH.31: 5 residues within 4Å:- Chain C: E.153, A.154, P.155, W.427, E.431
Ligand excluded by PLIPEOH.37: 7 residues within 4Å:- Chain D: P.112, K.113, I.114, A.146, R.147, R.148
- Chain F: L.71
Ligand excluded by PLIPEOH.38: 6 residues within 4Å:- Chain D: D.46, R.115, F.116, T.117
- Chain F: R.138, T.158
Ligand excluded by PLIPEOH.39: 3 residues within 4Å:- Chain D: E.55, H.56, K.172
Ligand excluded by PLIPEOH.40: 2 residues within 4Å:- Chain D: N.4, Q.6
Ligand excluded by PLIPEOH.47: 8 residues within 4Å:- Chain E: L.45, V.53, G.182, P.183, P.184, Y.327
- Chain F: E.70
- Ligands: EDO.46
Ligand excluded by PLIPEOH.48: 9 residues within 4Å:- Chain D: E.149
- Chain E: K.54, A.55, K.56, E.61, E.90, K.186, W.325
- Ligands: EDO.46
Ligand excluded by PLIPEOH.49: 3 residues within 4Å:- Chain E: S.141, F.142, H.143
Ligand excluded by PLIPEOH.50: 4 residues within 4Å:- Chain D: N.111
- Chain E: V.87, H.88, A.89
Ligand excluded by PLIPEOH.51: 5 residues within 4Å:- Chain E: E.153, A.154, P.155, W.427, E.431
Ligand excluded by PLIPEOH.57: 7 residues within 4Å:- Chain B: L.71
- Chain F: P.112, K.113, I.114, A.146, R.147, R.148
Ligand excluded by PLIPEOH.58: 6 residues within 4Å:- Chain B: R.138, T.158
- Chain F: D.46, R.115, F.116, T.117
Ligand excluded by PLIPEOH.59: 3 residues within 4Å:- Chain F: E.55, H.56, K.172
Ligand excluded by PLIPEOH.60: 2 residues within 4Å:- Chain F: N.4, Q.6
Ligand excluded by PLIP- 6 x NI: NICKEL (II) ION(Non-covalent)
NI.12: 3 residues within 4Å:- Chain B: H.14, E.18, E.160
6 PLIP interactions:3 interactions with chain B, 3 Ligand-Water interactions- Metal complexes: B:H.14, B:E.18, B:E.160, H2O.19, H2O.19, H2O.27
NI.13: 4 residues within 4Å:- Chain B: M.2
- Chain F: E.55, H.56
- Ligands: EDO.15
4 PLIP interactions:1 interactions with chain F, 3 Ligand-Water interactions- Metal complexes: F:H.56, H2O.17, H2O.17, H2O.78
NI.32: 3 residues within 4Å:- Chain D: H.14, E.18, E.160
6 PLIP interactions:3 interactions with chain D, 3 Ligand-Water interactions- Metal complexes: D:H.14, D:E.18, D:E.160, H2O.47, H2O.47, H2O.55
NI.33: 4 residues within 4Å:- Chain B: E.55, H.56
- Chain D: M.2
- Ligands: EDO.35
4 PLIP interactions:1 interactions with chain B, 3 Ligand-Water interactions- Metal complexes: B:H.56, H2O.22, H2O.45, H2O.45
NI.52: 3 residues within 4Å:- Chain F: H.14, E.18, E.160
6 PLIP interactions:3 interactions with chain F, 3 Ligand-Water interactions- Metal complexes: F:H.14, F:E.18, F:E.160, H2O.75, H2O.75, H2O.83
NI.53: 4 residues within 4Å:- Chain D: E.55, H.56
- Chain F: M.2
- Ligands: EDO.55
4 PLIP interactions:1 interactions with chain D, 3 Ligand-Water interactions- Metal complexes: D:H.56, H2O.50, H2O.73, H2O.73
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Friemann, R. et al., Structural insight into the dioxygenation of nitroarene compounds: the crystal structure of nitrobenzene dioxygenase. J. Mol. Biol. (2005)
- Release Date
- 2005-05-04
- Peptides
- OXYGENASE-ALPHA NBDO: ACE
OXYGENASE-BETA NBDO: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AB
BD
BF
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.50 Å
- Oligo State
- hetero-3-3-mer
- Ligands
- 3 x FES: FE2/S2 (INORGANIC) CLUSTER(Non-covalent)
- 3 x FE: FE (III) ION(Non-covalent)
- 3 x 3NT: 3-NITROTOLUENE(Non-covalent)
- 18 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 27 x EOH: ETHANOL(Non-functional Binders)
- 6 x NI: NICKEL (II) ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Friemann, R. et al., Structural insight into the dioxygenation of nitroarene compounds: the crystal structure of nitrobenzene dioxygenase. J. Mol. Biol. (2005)
- Release Date
- 2005-05-04
- Peptides
- OXYGENASE-ALPHA NBDO: ACE
OXYGENASE-BETA NBDO: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AB
BD
BF
B